mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.02 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.096 |
0.03 |